Menu Close

Articles on The business of pharmaceuticals

Displaying all articles

The first Pfizer-BioNTech COVID-19 vaccine dose in Canada sits ready for use at The Michener Institute in Toronto in mid-December 2020, less than a year from when the World Health Organization declared COVID-19 a pandemic. THE CANADIAN PRESS/Frank Gunn

Big Pharma’s COVID-19 reputation boost may not last — here’s why

If Big Pharma wants to achieve the ultimate image makeover, it must capitalize on the current public good will about its COVID-19 vaccines by prioritizing socially responsible practices.
Until the late 19th century, patenting medicines was considered by some as controversial and even unethical. S. Vannini/De Agostini Editorial

The US drug industry used to oppose patents – what changed?

The pharmaceutical industry overall has been deeply opposed to waiving COVID-19 vaccine patents, but a historian of the industry explains that drug companies once opposed patents altogether.

Top contributors